P621 Real-world Effectiveness and Safety of Vedolizumab and Anti-Tnf in Biologic-Naive Crohn’s Disease Patients: Results from the EVOLVE Study
Journal of Crohn's and colitis(2019)
Abstract
BackgroundThis multi-country, retrospective chart review study assessed the effectiveness and safety of vedolizumab (VDZ) compared with anti-tumour necrosis factors (anti-TNF) agents in a real-world cohort of biologic (bio)-naïve Crohn's disease (CD) patients.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined